# Pizarra — PT-pseudo_2ef22b5dd08e (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_2ef22b5dd08e
Task: 1

Encounter: Urology - outpatient on 18 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 66-year-old male
  - PSA: 9.3 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.296 ng/mL²
  - PSA velocity: 1.34 ng/mL/yr
  - Prior PSA: 6.2 ng/mL
  - Prostate volume: 31.46 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8335312 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 9.3 ng/mL. PI-RADS 4. PSAD 0.30. Prostate volume 31 mL. csPCa 0.83.

Vitals: weight 75 kg, height 184 cm, BMI 22.2, BP 136/76 mmHg, HR 71 bpm. Smoking: Ex-smoker (24 pack-yr, quit 2020).

Chief complaint: Clinical reassessment indicated due to a persistent upward PSA trajectory coupled with recent multiparametric magnetic resonance imaging results.

History: At 66 years of age, this semi-retired harbour pilot seeks review concerning his prostate-specific antigen trajectory, accompanied by a longstanding record of moderate lower urinary tract symptoms (IPSS 8/35). He shares an assisted-living residence with his spouse, who serves as his main point of contact. Physical activity remains a priority, featuring three weekly cycling sessions covering roughly 30 km each, balanced with an alcohol intake of 8 units weekly. His smoking history totals 24 pack-years, though he ceased tobacco use in 2020. Ocular limitations necessitate large-print documents. Recent medical engagements include a gastroenterology visit for standard colonoscopy screening, pulmonary function testing, and a baseline chest radiograph. A laparoscopic gallbladder removal occurred in 2015, entirely separate from his present urological evaluation. He maintains no active comorbidities, takes no prescribed medications, manages occasional seasonal allergies with non-prescription antihistamines, and carries no prior biopsy history. No unexplained weight reduction, skeletal discomfort, or blood in the urine has been reported. General health otherwise appears stable.

Physical examination: Per rectum: Normal DRE; digital assessment reveals a uniformly enlarged gland exhibiting consistent firmness without discrete irregularities or lateralised masses. Cardiovascular and respiratory auscultation demonstrate regular rhythms and clear field expansion. Abdominal percussion and palpation confirm a pliable, non-tender cavity lacking palpable hepatosplenomegaly or abnormal growths.

Patient info: harbour pilot (semi-retired); Married; Lives in assisted-living facility.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 8 units / week; exercise Cycling 3x/week, ~30 km; IPSS score: 8/35 (moderate LUTS).

Recent other appointments: Gastroenterology — surveillance colonoscopy; Radiology — chest X-ray (routine); Pulmonary function test — known COPD follow-up.
Admin: Visual impairment: large-print correspondence requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.80 +/- 0.14   (95% CI 0.45-0.99)

Where the uncertainty comes from:
  - aleatoric  dA = 0.12  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.08  (few labelled cases resemble this one)
  - 7.5 effective neighbours out of 10; 4 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {yes}

TIER 'firm': A +/- 1.96*dA does not cross the 0.5 threshold. On the 91 labelled cases this tier was never wrong, but it only covered 17 of them, so the 95% CI on that accuracy still reaches down to ~0.75. Treat it as a strong prior that should only be overturned by explicit contradicting evidence.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=4.0, bx_ord=0.0, psa=9.3, age=66.0, psad=0.296, dre_ord=0.0, vol=31.46, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
  The statistical recommender relied only on the structured panel. It could not weigh the PSA velocity (1.34 ng/mL/yr) and the prior PSA (6.2 ng/mL), which indicate a significant recent rise, against the PI-RADS 4 score and the high csPCa probability (0.8335312). It also missed the context provided by the full mpMRI report and the laboratory panel, which might contain crucial information regarding the aggressiveness or extent of the lesion suggested by the PI-RADS 4.

WHY THE SUGGESTION COULD BE WRONG
  The prior suggests biopsy based on a high probability (0.80), but this is based only on limited structured data. The high csPCa probability (0.83) combined with a PI-RADS 4 score warrants caution, especially given the prior biopsy status is 'None'. The prior's wide confidence interval (0.45-0.99) suggests high uncertainty, which is exacerbated by the fact that the prior has not seen the actual imaging or trend data.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
  <document> radiology / mpMRI report -> If the report details high-risk features or specific lesion characteristics, it could shift the decision towards or away from biopsy.
  <document> PSA history (trend) -> If the trend is accelerating or if the recent rise is highly significant, it would strengthen the case for biopsy.
  <document> laboratory results -> If the lab panel shows any markers (e.g., PSA density, other inflammatory markers) that contradict the high csPCa probability, it would modify the risk assessment.
  <document> previous GP / urology consultation notes -> These notes might contain context regarding the LUTS or any prior discussions about the PSA trajectory that the structured panel omits.

## [4] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
  One block per document you opened. Quote the values and phrases that matter, verbatim and with units. Numbers, lesion descriptions, dates, explicit radiologist or clinician recommendations. Do not paraphrase a number. If a document turned out to be uninformative, say so in one line.

  **radiology / mpMRI report**
  {"case_id": "PT-pseudo_2ef22b5dd08e", "radiology_report": "Subject: Prostate Multiparametric MRI | Date: 15 Feb 2025 | Facility: Radboudumc\n\nClinical Indication:\nAssessment requested due to a current serum prostate-specific antigen concentration of 9.3 ng/mL alongside a previous PI-RADS 4 classification.\n\nFINDINGS:\nMeasured organ bulk totals 31.46 mL. T2 sequences highlight a discrete hypointense area situated at the left peripheral zone base-to-mid transition, spanning roughly 14 mm at its widest point. Apparent diffusion coefficient mapping confirms pronounced restriction, mirrored by dark signal on the DWI traces. Contrast kinetics demonstrate early, localized uptake compared to adjacent tissue. Bilateral seminal vesicles retain normal architecture. Margins remain intact with no extracapsular spread or suspicious nodal enlargement detected.\n\nIMPRESSION:\nPI-RADS 4 lesion in the left peripheral zone (base-to-mid), 14 mm.\nProstate volume: 31.46 mL.\nPSA density: 0.296 ng/mL/mL.\ncsPCa predicted probability 0.8335312."}

  **psa_trend**
  {"case_id": "PT-pseudo_2ef22b5dd08e", "psa_trend": [{"date": "Jul 2022", "val": 6.7}, {"date": "May 2023", "val": 4.0}, {"date": "Apr 2024", "val": 4.4}, {"date": "Feb 2025", "val": 9.3}]}

  **lab_results**
  {"case_id": "PT-pseudo_2ef22b5dd08e", "laboratory_results": [{"name": "PSA", "val": "9.3 ng/mL", "date": "11 Jan 2025", "flag": "H"}, {"name": "Free PSA", "val": "1.40 ng/mL", "date": "11 Jan 2025", "flag": ""}, {"name": "%Free PSA", "val": "15%", "date": "11 Jan 2025", "flag": "L"}, {"name": "Haemoglobin", "val": "14.5 g/dL", "date": "11 Jan 2025", "flag": ""}, {"name": "WBC", "val": "7.9 x10^9/L", "date": "11 Jan 2025", "flag": ""}, {"name": "Platelets", "val": "141 x10^9/L", "date": "11 Jan 2025", "flag": ""}, {"name": "Creatinine", "val": "89 umol/L", "date": "11 Jan 2025", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "11 Jan 2025", "flag": ""}, {"name": "Testosterone", "val": "9.8 nmol/L", "date": "11 Jan 2025", "flag": ""}, {"name": "Alkaline phosphatase", "val": "68 U/L", "date": "11 Jan 2025", "flag": ""}, {"name": "LDH", "val": "175 U/L", "date": "11 Jan 2025", "flag": ""}]}

  **previous_notes**
  {"case_id": "PT-pseudo_2ef22b5dd08e", "previous_notes": [{"date": "21 Oct 2024", "author": "Dr. C. Peters (GP)", "text": "21 Oct 2024 - General Practitioner: Clinical check-in focused on tracking prostate-specific antigen levels. The most recent measurement, obtained in April 2024, registered at 6.2 ng/mL, indicating a decline from earlier highs. Urinary symptoms remain absent beyond his established lower urinary tract complaints."}, {"date": "01 Mar 2023", "author": "Dr. C. Peters (GP)", "text": "01 Mar 2023 - General Practitioner: Office visit initiated to address rising prostate-specific antigen values. Laboratory data returned a level of 8.7 ng/mL. Digital rectal assessment yielded normal findings."}]}

NOT RETRIEVED
  get_family_history - Not called as per retrieval economy rules.

WHAT THE EVIDENCE SUPPORTS
  FOR sampling this patient now:
  - PSA velocity of 1.34 ng/mL/yr, indicating a significant recent rise.
  - PI-RADS 4 lesion in the left peripheral zone (base-to-mid), 14 mm, with pronounced diffusion restriction.
  - csPCa predicted probability of 0.8335312.
  - Prior biopsy status is 'None'.

  AGAINST sampling this patient now:
  - DRE findings are Normal.
  - Margins remain intact with no extracapsular spread or suspicious nodal enlargement detected on MRI.
  - Free PSA is 15% (which is not explicitly stated as a strong negative marker, but is a factor).

WHERE THIS LEANS
  The retrieved evidence strongly supports the statistical prior by showing a high-risk imaging finding (PI-RADS 4) combined with a significant PSA velocity and high predicted cancer probability, which aligns with the prior's suggestion for biopsy.

[Sections actually revealed in this consultation: radiology_report, psa_trend, laboratory_results, previous_notes. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [5] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [6] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the patient presents with a PI-RADS 4 lesion (14 mm) and a high csPCa predicted probability of 0.8335312. This is strongly supported by a significant PSA velocity of 1.34 ng/mL/yr and a recent PSA rise from 4.4 to 9.3 ng/mL. The evidence converges on sampling due to the high-risk imaging finding combined with dynamic PSA changes, overriding the lack of suspicious DRE findings.

Variables that carried weight: age=noted, dre=noted, psa=decisive, vol=noted, psad=important, pirads=decisive
Sections revealed: radiology_report, psa_trend, laboratory_results, previous_notes
